On Friday, Facebook Inc (NASDAQ:FB)’s shares declined -1.53% to $107.10.
FB has 68.70% institutional ownership while its EPS ratio was 1.00. The company has 2.27 billion shares outstanding while market capitalization of the company was $302.86 billion. Price to book ratio was -7.59. Net profit margin of the company was 28.30% while gross profit margin was 82.60%. Stock volatility for the month was booked as 2.06% while for the week was recorded as 2.05%.
The mean estimate for the short term price target for Facebook Inc (NASDAQ:FB) stands at $123.43 according to 46 Analysts. The higher price target estimate for the stock has been calculated at $155.00 while the lower price target estimate is at $68.00.
Analysts mean recommendation for the stock is 1.70. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Facebook, Inc. is a social networking company. The Company is engaged in developing products that enables users to connect and share through mobile devices and personal computers.
AstraZeneca plc (ADR) (NYSE:AZN)’s shares dropped -1.32% to $32.09.
AZN Its past 5-day performance at 0.63%. So far in 2015, the company has a year-to-date performance of -8.81%. The stock, as of last close, traded 8.78% up from its 52 week low and was -11.95% below its 52 week high. Its latest closing price was -3.32% below the SMA200 while the distance from SMA 50 and SMA 20 was -0.18% and 0.89% respectively.
The mean estimate for the short term price target for AstraZeneca plc (ADR) (NYSE:AZN) stands at $36.86 according to 4 Analysts. The higher price target estimate for the stock has been calculated at $40.45 while the lower price target estimate is at $34.00.
Analysts mean recommendation for the stock is 2.50. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. The Company discovers, develops and commercializes prescription medicines for Cardiovascular and Metabolic diseases; Oncology; Respiratory, Inflammation and Autoimmunity, Infection, Neuroscience and Gastrointestinal.
At the end of Friday’s trade, Zoetis Inc (NYSE:ZTS)‘s shares surged 1.12% to $45.97.
ZTS has market capitalization of $22.89 billion. Its current ratio was 2.10 while its shares were above its 50 days simple moving average with 5.68%. The company offered earning per share of $0.88 while its 498.33 million shares were outstanding. YTD performance of the company was 6.83%. Stock volatility for the week was 3.16% while for the month it was shown at 3.08%.
The mean estimate for the short term price target for Zoetis Inc (NYSE:ZTS) stands at $52.58 according to 12 Analysts. The higher price target estimate for the stock has been calculated at $62.00 while the lower price target estimate is at $45.00.
Analysts mean recommendation for the stock is 1.90. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.